European Federation for Pharmacology Societies

European Federation for Pharmacology Societies
Name	European Federation for Pharmacology Societies
Abbreviation	EFPS
Formation	20th century
Type	Learned society
Headquarters	Europe
Region served	Europe
Membership	National pharmacology societies
Leader title	President

Contents

European Federation for Pharmacology Societies is a pan-European umbrella organization that represents national and thematic pharmacology societies across the European Union, United Kingdom, Norway, Switzerland, Iceland and other European states, liaising with international bodies such as the World Health Organization, International Union of Basic and Clinical Pharmacology, and the European Medicines Agency. It supports coordination among scientists linked to institutions like the Karolinska Institutet, University of Oxford, Sorbonne University, and the University of Milan, while engaging with funding agencies including the European Research Council, Wellcome Trust, and the National Institutes of Health. The federation interacts with regulatory and policy actors such as the Council of Europe, European Commission, European Parliament, and the European Council.

History

The federation traces roots to post-war scientific consolidation efforts similar to developments seen with the Council for International Organizations of Medical Sciences and the International Council for Science, when national delegations from societies like the Royal Society of Medicine, Deutsche Gesellschaft für Pharmakologie, Société Française de Pharmacologie, and the Italian Pharmacological Society sought coordinated representation at forums including the World Health Assembly and the Organisation for Economic Co-operation and Development. Early meetings involved delegates from institutions such as the Max Planck Society, Karolinska Institutet, Instituto Superiore di Sanità, and the Flemish Institute. Milestones included formal statutes ratified in the era of Treaty of Maastricht-era European integration, engagement with the European Medicines Agency in the wake of the AIDS crisis, and participation in pan-European initiatives influenced by the Horizon 2020 programme and the Lisbon Strategy. Key figures and affiliated scientists have included members connected to the Royal Society, Academy of Medical Sciences (United Kingdom), French Academy of Sciences, and the Accademia dei Lincei.

The federation's governance mirrors structures found in bodies like the European Research Council, featuring an executive committee, standing committees, and national delegates drawn from societies such as the British Pharmacological Society, German Pharmacological Society, Polish Pharmacological Society, Spanish Society of Pharmacology, and the Hellenic Pharmacological Society. Offices coordinate with universities including University College London, Heidelberg University, University of Barcelona, and Universität Zürich. Membership categories accommodate national societies, specialist groups connected to the European Society of Cardiology, European Respiratory Society, European Society for Clinical Microbiology and Infectious Diseases, and smaller regional bodies like the Nordic Pharmacological Network and the Baltic Pharmacology Association. Leadership roles have affinities with honors from the Royal Society of Edinburgh, Deutsche Forschungsgemeinschaft, and awards such as those from the European Molecular Biology Organization.

Core activities align with advocacy to entities like the European Commission, consultation for regulatory agencies including the European Medicines Agency and the Pharmacovigilance Risk Assessment Committee, and scientific coordination resembling networks such as the European Research Area and the European Platform for Rare Disease Research. It issues position statements relevant to directives like the Clinical Trials Directive and engages with ethical frameworks influenced by the European Court of Human Rights and the Nuremberg Code-associated discourse. The federation runs thematic working groups analogous to committees at the World Health Organization and collaborates with societies such as the European Society of Cardiology, European Association for the Study of Diabetes, European Society for Paediatric Research, and patient-centered organizations including European Patients' Forum. It supports translational efforts between laboratories at the Max Planck Institute for Biophysical Chemistry, clinical centres such as Karolinska University Hospital, and industry partners like AstraZeneca, Novartis, Sanofi, and Roche.

The federation organizes biennial pan-European congresses resembling meetings held by the Federation of European Neuroscience Societies and partners with national meetings such as the British Pharmacological Society Annual Meeting, German Pharmacology Congress, and the Società Italiana di Farmacologia conference. Conferences attract delegations from universities including University of Cambridge, University of Edinburgh, Université de Genève, and research institutes like the Francis Crick Institute and European Molecular Biology Laboratory. Publication outlets and communication channels include collaborative reports, position papers, and proceedings similar to journals like British Journal of Pharmacology, Pharmacological Reviews, European Journal of Clinical Pharmacology, and the Journal of Pharmacology and Experimental Therapeutics, with editorial interactions involving publishers such as Springer Nature, Wiley-Blackwell, and Elsevier. The federation supports themed symposia on topics of interest to audiences of the European Society for Clinical Microbiology and Infectious Diseases and the European Society for Paediatric Endocrinology.

Education programs align with training initiatives like those from the European Society of Cardiology and the European Respiratory Society, offering workshops, summer schools, and mentoring schemes in partnership with universities such as Trinity College Dublin, Technische Universität München, University of Leiden, and the University of Leuven. Grant schemes complement funding structures provided by the European Research Council, Marie Skłodowska-Curie Actions, and national agencies including the Deutsche Forschungsgemeinschaft and Agence Nationale de la Recherche. Scholarships and fellowship programs link early-career scientists to laboratories at the Wellcome Sanger Institute, Babraham Institute, and clinical sites like Guy's and St Thomas' NHS Foundation Trust.

Partnerships span intergovernmental and non-governmental organizations such as the World Health Organization, Council of Europe, European Commission, and professional networks including the International Union of Basic and Clinical Pharmacology, Federation of European Neuroscience Societies, European Chemistry Thematic Network Association, and societies like the European Society of Anaesthesiology and European Association of Surgical Trainees. Collaborative research consortia have involved institutions like the Institut Pasteur, CERN-adjacent biomedical initiatives, Max Delbrück Center for Molecular Medicine, and multinational pharmaceutical consortia with Pfizer, GlaxoSmithKline, and Bayer. The federation participates in policy dialogues alongside European Patients' Forum, European Public Health Alliance, and standards bodies similar to European Committee for Standardization.

Category:Pharmacology organizations